IVGSX | VIVIX | IVGSX / VIVIX | |
Total Expense Ratio | 0.89 | 0.04 | 2,225% |
Annual Report Gross Expense Ratio | 0.89 | 0.04 | 2,225% |
Fund Existence | 32 years | 27 years | - |
Gain YTD | -11.306 | 6.730 | -168% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 156M | 195B | 0% |
Annual Yield % from dividends | 1.20 | 2.19 | 55% |
Returns for 1 year | -6.28 | 9.75 | -64% |
Returns for 3 years | 0.69 | 34.32 | 2% |
Returns for 5 years | 25.09 | 74.87 | 34% |
Returns for 10 years | -13.46 | 116.26 | -12% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LGLOX | 55.50 | 0.42 | +0.76% |
Lord Abbett Growth Leaders F3 | |||
BLYYX | 36.02 | 0.18 | +0.50% |
American Beacon Man Lg Cp Growth Y | |||
FOSBX | 29.81 | 0.11 | +0.37% |
Tributary Small Company Instl Plus | |||
WASYX | 23.64 | 0.01 | +0.04% |
Macquarie Asset Strategy Fund Cl Y | |||
FNDMX | 13.50 | -0.01 | -0.07% |
Fidelity Series Sust Non-US Dev Mrkt Fd |